COPD Flashcards

(44 cards)

1
Q

Usually able to maintain adeq oxygenation for longer time period
Pink puffer d/t pursed lips, skin color and thin body habitus

A

Emphysema predominant COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hypoxemia and resp acidosis common, cor pulmonale from pulm HTN
Blue bloaters d/t cyanosis and overweight

A

Chronic bronchitis predominant COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define chronic bronchitis

A

Chronic productive cough for 3 mo, during 2 consecutive years w/ no other cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Structural changes in chronic bronchitis

A

Mucous gland hyperplasia
Narrowing of bronchioles
Bronchial squamous metaplasia
Loss of ciliary transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Obstruction is inspiratory and expiratory

A

chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathologic enlargement of the the air spaces distal to the bronchioles d/t the destruction of the alveolar walls

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Airflow obstruction mostly during exhalation

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Not a/w sig hypoxemia

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Destruction of alveolar bed, resulting in reduced CO2 diffusing capacity
Hypercarbia

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Primarily eosinophil mediated chronic inflammatory disorder fo the airways

A

asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Emphysema onset

A

Usually after age 50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chronic bronchitis onset

A

late 30’s-40’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Progressive, constant, severe dyspnea

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intermittent, mild to moderate dyspnea

A

chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Persistent cough and sputum

A

chronic bronchitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Absent to mild cough and sputum

A

emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clear, mucoid sputum

A

Emphysema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mucopurulent sputum

A

chronic bronchitis

19
Q

Pt presents with dyspnea, chronic cough, sputum production. Cough is usually in the morning.

20
Q

Dyspnea that is progressive, persistent, worse with exercise, worse with resp infxn

A

Consider COPD

21
Q

Primary cause of COPD

A

SMOKING

  • stimulates elastase enzymatic activity causing degenerative changes in alveolar structures
  • Causes release of cytotoxic oxygen radicals
22
Q

Causes premature emphysema

A

alpha-1 antitrypsin def

-inhibits elastase and enz, if not enough antitrypsin, they destroy lung tissue

23
Q

Exam findings of emphysema

A
Increase AP diameter
Distant breath sounds
Hyper resonant 
Pursed lip breathing 
Use of accessory muscles
24
Q

Emphysema ECG

A

sinus tachycardia
peaked P waves
Right axis deviation
RVH

25
Hyperinflation (possibly with bullae) Flattening of diaphragm Enlargement of restrosternal air space CXR findings suggest:
Emphysema
26
Cardiac enlargement Pulmonary congestion Increased lung markings CXR findings suggest:
Chronic bronchitis
27
PFT: FVC (forced vital capacity)
Usually normal in COPD vs low in restrictive disease
28
PFT: FEV1 (forced expiratory vol in 1 sec)
Decreased in COPD | reversible in asthma
29
PFT: FEV1/FVC
decreased FEV1 w/ normal FVC suggets obstructive airway disease
30
FEV1/FVC 80% predicted | W/ or w/o sx
Mild COPD
31
FEV1/FVC <80% | Dyspnea w/ exertion, w/ or w/o cough and sputum production
Mod COPD
32
FEV1/FVC <50% plus resp fail
Very severe COPD
33
FEV1/FVC <50% | Increase DOE, fatigue, repeated exacerbations
Severe COPD
34
Mainstay of COPD therapy
B2-agonists and anticholinergics (bronchodilators) Inhaled preferred
35
Provides bronchodilation as well as reduce air trapping in lungs Well tolerated, less cardiac fx, better efficacy
Anitcholinergics - Short: ipatropium bromide (Atrovent) - Long: tiotropium bromide (Spiriva)
36
Good bronchodilation fx, no fx on sputum/secretions
B2-agonists - Short: Albuterol - Long: Salmetrol, formoterol
37
Inhaled for maintenance Reduce mucosal edema and inflamtn Inhibit prostaglandins Increase response to beta adreergics
Corticosteroids
38
PDE-4 inhibitor for refractory cases
Anti-inflam fx | -suppresses cytokine release and inhibits lung infiltration by neutrophils and other WBCs
39
Tx of alpha 1 anti-trypsin def
Antiprotease injections
40
Indication for O2 therapy -must use at least 12 hours/d
pO2 less than 55 or O2 sat <88% on RA
41
Why pursed lip breathing?
Increase resistance to air outflow, increases intrabronchial pressure to keep bronchi poen
42
Macrolides
Azithromycin | Clarithromycin
43
Flouroquinolones
Levofloxacin | Moxifloxacin
44
Cephalosporins
Cefdinir | -does not cover typical pathogens